Paper76996
Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies.
Bodensteiner JB and 1 other. Neurology, 1978. Cited by 366 papers, by iCite.
Cite this record
ConductScience Library. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Papers, record 76996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76996
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium | Major topic |
| Muscles | Major topic |
| Muscular Diseases | Major topic |
| Muscular Dystrophies | Major topic |
| Biopsy | |
| Histocytochemistry | |
| Humans | |
| Staining and Labeling |
Source PubMed
Cited by89
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 366 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40490752 | Extensive striated muscle damage in a rat model of Duchenne muscular dystrophy with Dmd exons 10-17 duplication. | Skelet Muscle | 2025 | https://conductscience.org/library/papers/40490752 | PubMed |
| 39718509 | Reduced voltage-activated Ca2+ release flux in muscle fibers from a rat model of Duchenne dystrophy. | J Gen Physiol | 2025 | https://conductscience.org/library/papers/39718509 | PubMed |
| 37681933 | Calcineurin-Dependent Homeostatic Response of C. elegans Muscle Cells upon Prolonged Activation of Acetylcholine Receptors. | Cells | 2023 | https://conductscience.org/library/papers/37681933 | PubMed |
| 37578579 | LED therapy plus idebenone treatment targeting calcium and mitochondrial signaling pathways in dystrophic muscle cells. | Cell Stress Chaperones | 2023 | https://conductscience.org/library/papers/37578579 | PubMed |
| 37240001 | Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240001 | PubMed |
| 36583079 | Modeling neuromuscular diseases in zebrafish. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/36583079 | PubMed |
| 36555721 | Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555721 | PubMed |
| 36385509 | Sulfur amino acid supplementation displays therapeutic potential in a C. elegans model of Duchenne muscular dystrophy. | Commun Biol | 2022 | https://conductscience.org/library/papers/36385509 | PubMed |
| 35624880 | Taurine Administration Counteracts Aging-Associated Impingement of Skeletal Muscle Regeneration by Reducing Inflammation and Oxidative Stress. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624880 | PubMed |
| 34884796 | Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884796 | PubMed |
| 34575944 | Alisporivir Improves Mitochondrial Function in Skeletal Muscle of mdx Mice but Suppresses Mitochondrial Dynamics and Biogenesis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34575944 | PubMed |
| 34572419 | Effect of the Non-Immunosuppressive MPT Pore Inhibitor Alisporivir on the Functioning of Heart Mitochondria in Dystrophin-Deficient mdx Mice. | Biomedicines | 2021 | https://conductscience.org/library/papers/34572419 | PubMed |
| 34298968 | Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34298968 | PubMed |
| 34063069 | Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34063069 | PubMed |
| 33627403 | Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33627403 | PubMed |
| 33363799 | A child with duchenne muscular dystrophy: A case report of a rare diagnosis among Africans. | Clin Case Rep | 2020 | https://conductscience.org/library/papers/33363799 | PubMed |
| 33114289 | Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33114289 | PubMed |
| 33059738 | A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy. | Skelet Muscle | 2020 | https://conductscience.org/library/papers/33059738 | PubMed |
| 31980663 | Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy. | Sci Rep | 2020 | https://conductscience.org/library/papers/31980663 | PubMed |
| 31752977 | Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial. | Trials | 2019 | https://conductscience.org/library/papers/31752977 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/76996
GET https://conductscience.org/api/papers/v1/76996/cited_by?page=2